Skip to content

Insider · CIK 0001433241

Stephen K. Klasko M.D.

director

Files at TFX (TELEFLEX INC), DCGO (DocGo Inc.). First filing May 14, 2025, latest May 14, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$22k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

DCGO: DocGo Inc.

DCGOOct 9, 2026 · close 0.34

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
56Moderate
DCGObuy 5
DocGo Inc.
$22k
15,000 shares
-0% from low-75% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2025DCGO
DocGo Inc.
AGrant or award
Common Stock
+100,000$0.00$0115,000Sep 11, 2025
May 14, 2025DCGO
DocGo Inc.
POpen-market purchase
Common Stock
+15,000$1.49$22k15,000May 14, 2025
May 9, 2025TFX
TELEFLEX INC
AGrant or award
Common Stock
+1,357$0.00$09,333May 13, 2025
May 9, 2025TFX
TELEFLEX INC
AGrant or award
Stock Option / (Right to Buy)derivative
+2,226$0.00$02,226May 13, 2025
Feb 20, 2025TFX
TELEFLEX INC
MOption exercise
Common Stock
+2,674$121.00$324k9,827Feb 21, 2025
Feb 20, 2025TFX
TELEFLEX INC
FTax withholding
Common Stock
-1,851$174.82$324k7,976Feb 21, 2025
Feb 20, 2025TFX
TELEFLEX INC
MOption exercise
Stock Option / (Right to Buy)derivative
-2,674$0.00$00Feb 21, 2025
Nov 12, 2024DCGO
DocGo Inc.
AGrant or award
Options to purchase Common Stockderivative
+204,082$0.00$0204,082Nov 14, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen K. Klasko M.D.: insider trades and track record | InsiderTell